Anti-mesothelin CAR T-cells UCMYM802

**Semantic type:** Cell|Pharmacologic Substance

**Definition:** A preparation of T-lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) specific for the human tumor-associated antigen (TAA) mesothelin (MSLN), with potential immunomodulating and antineoplastic activities. Upon administration, anti-MSLN CAR T-cells UCMYM802 specifically target and kill MSLN-expressing tumor cells. MSLN, a cell surface glycoprotein involved in cell adhesion, is overexpressed in a variety of cancer cell types.

**Synonyms:** - Anti-MSLN CAR T-cells UCMYM802 - Anti-MSLN CAR-T Cells UCMYM802 - Anti-mesothelin CAR T Cells UCMYM802 - UCMYM 802 - UCMYM-802 - UCMYM802